Intellia Therapeutics Inc. (NASDAQ: NTLA) announced the U.S. Food and Drug Administration has removed the clinical hold on its MAGNITUDE-2 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE